Technical Briefing on Pyramax®

29 Apr 2016

On 20 April, Shin Poong Pharmaceutical Co. Ltd. and Medicines for Malaria Venture held a technical briefing at the Geneva Press Club.

The briefing addressed the clinical evidence that formed the basis of the EMA's positive scientific opinion for Pyramax, the implementation strategy to provide rapid access to this drug in malaria-endemic countries, and the vital role of Pyramax in malaria control, elimination and eradication.